AR015761A1 - Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades - Google Patents
Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedadesInfo
- Publication number
- AR015761A1 AR015761A1 ARP990101685A ARP990101685A AR015761A1 AR 015761 A1 AR015761 A1 AR 015761A1 AR P990101685 A ARP990101685 A AR P990101685A AR P990101685 A ARP990101685 A AR P990101685A AR 015761 A1 AR015761 A1 AR 015761A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- acid derivative
- methylpropionic acid
- atom
- prevention
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical class CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 206010052402 Gastrointestinal hypermotility Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 210000003445 biliary tract Anatomy 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000001883 cholelithiasis Diseases 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 208000001130 gallstones Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 201000001421 hyperglycemia Diseases 0.000 abstract 1
- 230000035873 hypermotility Effects 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 208000018936 intestinal hypermotility Diseases 0.000 abstract 1
- 230000037036 intestinal hypermotility Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 239000008177 pharmaceutical agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El derivado del ácido 2-metilpropionico está representado por la formula general (I), donde R1 representa un grupo hidroxi, un grupo alcoxi inferior o ungrupo aralquilo; R2 representa un grupo hidroxi, un grupo alquilo inferior o un átomo de halogeno; A representa un átomo de oxígeno o un grupo imino; el átomode C marcado con (R) representa un átomo de C en la configuracion R y el átomo de C marcado con (S) representa un átomo de C en la configuracion S; y sus salesfarmacéuticamente aceptables,que tienen excelentes efectos estimulantes de los beta3-adrenoceptores y son utiles como agentes para la prevencion o eltratamiento de la obesidad, la hiperglicemia, las enfermedades causadas por la hipermotilidad intestinal, la polaquiuria, la incontinencia urinaria, ladepresion o las enfermedades causadas por cálculos biliares o hipermotilidad del tracto biliar. Composicion farmacéutica y agente que incluye dicho derivadocomo componente activo. Un procedimiento para la fabricacion de una composicion farmacéutica que usa dicho derivado como constituyente esencial.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14202898 | 1998-04-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015761A1 true AR015761A1 (es) | 2001-05-16 |
Family
ID=15305697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990101685A AR015761A1 (es) | 1998-04-14 | 1999-04-13 | Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6696489B1 (es) |
| EP (1) | EP1072583B1 (es) |
| JP (1) | JP4212771B2 (es) |
| KR (1) | KR100576131B1 (es) |
| AR (1) | AR015761A1 (es) |
| AT (1) | ATE275126T1 (es) |
| AU (1) | AU768217C (es) |
| CA (1) | CA2328348C (es) |
| CO (1) | CO5021214A1 (es) |
| DE (1) | DE69919860T2 (es) |
| ES (1) | ES2228028T3 (es) |
| IL (1) | IL138994A (es) |
| MY (1) | MY122400A (es) |
| NO (1) | NO20005164L (es) |
| NZ (1) | NZ507486A (es) |
| PE (1) | PE20000423A1 (es) |
| TW (1) | TW581754B (es) |
| WO (1) | WO1999052856A1 (es) |
| ZA (1) | ZA200005589B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1146035T3 (da) * | 1999-01-21 | 2006-03-27 | Kissei Pharmaceutical | Krystalpolymorfi af aminoethylphenoxyeddikesyrederivat |
| JP3815496B2 (ja) | 2002-11-07 | 2006-08-30 | アステラス製薬株式会社 | 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤 |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| AU2004212381B2 (en) * | 2003-02-14 | 2008-08-21 | Kissei Pharmaceutical Co., Ltd. | Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| ITMI20061581A1 (it) * | 2006-08-04 | 2008-02-05 | Univ Bari | Ligandi del recettore beta-3 adrenergico e loro uso in terapia |
| TWI478712B (zh) | 2008-09-30 | 2015-04-01 | Astellas Pharma Inc | 釋控性醫藥組成物 |
| JP5849947B2 (ja) | 2010-03-29 | 2016-02-03 | アステラス製薬株式会社 | 放出制御医薬組成物 |
| US12097189B1 (en) | 2024-02-09 | 2024-09-24 | Astellas Pharma Inc. | Pharmaceutical composition for modified release |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4146638A (en) * | 1976-02-17 | 1979-03-27 | Boehringer Ingelheim Gmbh | N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines |
| ATE1994T1 (de) * | 1979-06-16 | 1982-12-15 | Beecham Group Plc | Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. |
| FR2750668B1 (fr) | 1996-07-03 | 1998-11-20 | Savard Franck | Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo |
| AU4320297A (en) * | 1996-09-26 | 1998-04-17 | Kissei Pharmaceutical Co. Ltd. | 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives |
| ID24062A (id) * | 1997-07-25 | 2000-07-06 | Kissei Pharmaceutical | Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing |
| PL341221A1 (en) * | 1997-12-18 | 2001-03-26 | Kissei Pharmaceutical | Derivatives of phenylaminoalkyl carboxylic acid and pharmacological compositions containing them |
-
1999
- 1999-04-07 KR KR1020007011387A patent/KR100576131B1/ko not_active Expired - Fee Related
- 1999-04-07 EP EP99913563A patent/EP1072583B1/en not_active Expired - Lifetime
- 1999-04-07 CA CA002328348A patent/CA2328348C/en not_active Expired - Fee Related
- 1999-04-07 AU AU31661/99A patent/AU768217C/en not_active Ceased
- 1999-04-07 DE DE69919860T patent/DE69919860T2/de not_active Expired - Lifetime
- 1999-04-07 NZ NZ507486A patent/NZ507486A/xx unknown
- 1999-04-07 WO PCT/JP1999/001836 patent/WO1999052856A1/ja not_active Ceased
- 1999-04-07 ES ES99913563T patent/ES2228028T3/es not_active Expired - Lifetime
- 1999-04-07 IL IL13899499A patent/IL138994A/en not_active IP Right Cessation
- 1999-04-07 AT AT99913563T patent/ATE275126T1/de not_active IP Right Cessation
- 1999-04-07 US US09/673,308 patent/US6696489B1/en not_active Expired - Fee Related
- 1999-04-07 JP JP2000543419A patent/JP4212771B2/ja not_active Expired - Fee Related
- 1999-04-08 TW TW088105577A patent/TW581754B/zh not_active IP Right Cessation
- 1999-04-09 MY MYPI99001392A patent/MY122400A/en unknown
- 1999-04-12 PE PE1999000296A patent/PE20000423A1/es not_active Application Discontinuation
- 1999-04-13 CO CO99021754A patent/CO5021214A1/es unknown
- 1999-04-13 AR ARP990101685A patent/AR015761A1/es unknown
-
2000
- 2000-10-11 ZA ZA200005589A patent/ZA200005589B/en unknown
- 2000-10-13 NO NO20005164A patent/NO20005164L/no unknown
-
2003
- 2003-02-05 US US10/358,214 patent/US6790865B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1072583A4 (en) | 2001-12-05 |
| WO1999052856A1 (en) | 1999-10-21 |
| PE20000423A1 (es) | 2000-05-22 |
| ZA200005589B (en) | 2002-01-11 |
| TW581754B (en) | 2004-04-01 |
| IL138994A0 (en) | 2001-11-25 |
| ATE275126T1 (de) | 2004-09-15 |
| AU3166199A (en) | 1999-11-01 |
| CO5021214A1 (es) | 2001-03-27 |
| IL138994A (en) | 2004-02-19 |
| JP4212771B2 (ja) | 2009-01-21 |
| ES2228028T3 (es) | 2005-04-01 |
| KR100576131B1 (ko) | 2006-05-03 |
| CA2328348A1 (en) | 1999-10-21 |
| CA2328348C (en) | 2009-03-03 |
| KR20010042683A (ko) | 2001-05-25 |
| NO20005164L (no) | 2000-12-12 |
| DE69919860T2 (de) | 2005-08-25 |
| AU768217C (en) | 2005-04-21 |
| DE69919860D1 (de) | 2004-10-07 |
| AU768217B2 (en) | 2003-12-04 |
| EP1072583A1 (en) | 2001-01-31 |
| EP1072583B1 (en) | 2004-09-01 |
| US20030166719A1 (en) | 2003-09-04 |
| NO20005164D0 (no) | 2000-10-13 |
| MY122400A (en) | 2006-04-29 |
| US6790865B2 (en) | 2004-09-14 |
| US6696489B1 (en) | 2004-02-24 |
| NZ507486A (en) | 2003-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR029600A1 (es) | Un derivado del acido fenoxiacetico, una composicion farmaceutica que lo contiene y agente util para la prevencion de enfermedades, uso de un derivado del acido fenoxiacetico para la fabricacion de una composicion farmaceutica para los tratamientos de dichas enfermedades y el procedimiento de fabric | |
| RU2009112207A (ru) | Конкретное глюкокортикостероидное соединение, обладающее противовоспалительной активностью | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| ES2295609T3 (es) | Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor. | |
| SV2002000245A (es) | Oxazolidinonas substituidas y su uso ref. lea 34122-sv | |
| MY146351A (en) | Compositions for treating infection in cattle and swine | |
| BR0015624A (pt) | Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| DE60238255D1 (de) | Azolsäure-derivate, allein oder kombiniert, zur behandlung von diabetes und dyslipidaemien; und zur behandlung von malignen erkrankungen | |
| BRPI0113042B8 (pt) | composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato | |
| NO20064282L (no) | Morfolinforbindelser | |
| BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| BR0308133A (pt) | Forma polimórfica cristalina de cloridrato de irinotecan | |
| BR0314754A (pt) | Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica | |
| AR017858A1 (es) | Derivados de acido fenilaminoalquilcarboxilico utiles como estimulantes de los beta3-adrenoceptores, composicion farmaceutica, estimulante de losbeta3-adrenoceptores, usos en la fabricacion de medicamentos y procedimiento de fabricacion | |
| AR015761A1 (es) | Un derivado del acido 2-metilpropionico,una composicion farmaceutica que lo incluye, uso de un derivado del acido 2-metilpropionico y un procedimiento parala fabricacion de una composicion farmaceutica para la prevencion o el tratamiento de enfermedades | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| MXPA02012730A (es) | Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide. | |
| IL151359A (en) | Esmolol formulation | |
| DE60130030D1 (de) | Verfahren zur behandlung von glaukom | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| BR0112957A (pt) | Composto, método de tratamento, uso de um composto, e, composição farmacêutica | |
| BRPI0506710A (pt) | composições farmacêuticas de liberação controlada | |
| BR0316123A (pt) | Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |